Anavex Life Sciences
AVXL
#7683
Rank
โ‚น33.23 B
Marketcap
โ‚น371.96
Share price
1.99%
Change (1 day)
-52.22%
Change (1 year)

EPS for Anavex Life Sciences (AVXL)

EPS in 2025 (TTM): -โ‚น48.51

According to Anavex Life Sciences 's latest financial reports the company's current EPS (TTM) is -โ‚น51.71. In 2024 the company made an earnings per share (EPS) of -โ‚น47.17 an increase over its 2023 EPS that were of -โ‚น54.43.

EPS history for Anavex Life Sciences from 2004 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น48.512.82%
2024-โ‚น47.17-13.33%
2023-โ‚น54.43-3.23%
2022-โ‚น56.2514.81%
2021-โ‚น48.9920%
2020-โ‚น40.82-16.67%
2019-โ‚น48.9938.46%
2018-โ‚น35.3818.18%
2017-โ‚น29.94-21.43%
2016-โ‚น38.10-35.38%
2015-โ‚น58.97-36.27%
2014-โ‚น92.54112.5%
2013-โ‚น43.55-58.62%
2012-โ‚น105.24-0%
2011-โ‚น105.24-29.27%
2010-โ‚น148.7851.85%
2009-โ‚น97.98-0%
2008-โ‚น97.98237.5%
2007-โ‚น29.03
2006N/A-100%
2005-โ‚น3.63499.97%
2004-โ‚น0.60

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Ligand Pharmaceuticals
LGND
โ‚น216.82-519.30%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-โ‚น4.54-91.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
โ‚น90.72-275.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-โ‚น5,534 10,601.75%๐Ÿ‡บ๐Ÿ‡ธ USA